Personalized microRNA-based Support for Cancer, Viral Conditions & Lyme
Autologous Precision Therapy
Q-REstrain® is a highly individualized service designed around each patient’s unique biological profile. Using a standard blood sample, advanced laboratory analysis is performed to identify specific molecular patterns and genetic signals. This information is then used to develop a customized approach intended to interact only with selected genetic targets relevant to the individual.
Targeted Gene Regulation
Q-REstrain® is based on advanced RNA-based science that focuses on regulating specific genetic signals associated with disease processes. The approach uses small, sequence-specific oligonucleotide molecules designed to interact with targeted messenger RNA (mRNA).
By selectively binding to these mRNA signals, Q-REstrain® is designed to reduce the expression of certain proteins involved in abnormal cellular activity and metabolic pathways. This targeted gene-regulation strategy aims to disrupt biological signals that may support the persistence or progression of cancer cells, viral activity, or chronic infections such as Lyme disease—while leaving unaffected genetic pathways untouched.
Precision. Personalization. Molecular Focus.
One of the most significant advantages of Q-REstrain is its personalized nature. Unlike conventional treatments, which often take a one-size-fits-all approach, Q-REstrain is tailored to each patient’s condition and genetic makeup. This customization may increase the likelihood of a successful outcome and reduce the risk of harmful side effects.
Targeted Therapy:
Because Q-REstrain specifically targets the genetic material of cancer cells or pathogens, it minimizes damage to healthy cells. This can result in fewer side effects than generalized treatments like chemotherapy or radiation.
Less Invasive:
Q-REstrain is administered intravenously and does not require surgery or intensive medical procedures. This is a welcome alternative to more aggressive treatment options for many patients.
Fewer Side Effects:
By focusing on the genetic code of abnormal cells or viruses, Q-REstrain may reduce the risk of unwanted side effects often associated with conventional treatments, such as nausea, fatigue, and immune system suppression.
Complementary Therapy:
Q-REstrain can also be used with other treatments, such as chemotherapy or antiviral medications, to enhance their effectiveness and support the body’s natural defenses.
Q-REstrain may be an option for individuals dealing with various chronic conditions, especially those who have not responded well to conventional treatments. It is most commonly used for patients with certain types of cancer or persistent viral infections, such as Lyme disease or Epstein-Barr virus.
It’s important to note that not everyone is a candidate for Q-REstrain. Your healthcare provider will conduct a thorough evaluation to determine if this treatment is appropriate based on your unique medical history and condition.
So, Q-REstrain is this clever therapy that uses your own body’s stuff to fight off specific health problems. Think of it like this: scientists at a lab called RGCC that can find the exact genetic instructions that make things like cancer cells, Lyme disease, or even some viruses act up. Then, they use tiny molecules, like messengers called microRNAs that they get from your blood, to tell those bad instructions to quiet down. This whole process is based on something called RNA Interference, or RNAi. It’s like a super-specific way of turning off the volume on the genes causing trouble.
Here’s how it works step by step:
It’s like an exact way of telling the troublemakers in your body to stop causing problems!
This is where it gets exciting! Q-REstrain might be an option for a few different health challenges.
Thinking about how this technology could help people with various conditions is exciting!
There are some auspicious potential benefits to Q-REstrain:
It’s important to remember that this is a relatively new area, and more research is always ongoing to understand the benefits and how best to use Q-REstrain fully.
You might be wondering why you should consider exploring Q-REstrain with us here at NP Health Clinic™. Well, NP Andrena McDonald, our Nurse Practitioner, firmly believes in looking for the root cause of health issues and using a mix of conventional and holistic approaches.
NP Andrena is passionate about helping patients feel energetic and live their best lives. She started this practice to connect with people and work together to understand what’s driving their health challenges. We’re all about taking a comprehensive view of your health and exploring innovative options that might offer new possibilities.
We’re excited about Q-REstrain’s potential because it aligns with our philosophy of targeting the underlying issues and using personalized approaches. We’re committed to staying informed about the latest advancements in healthcare and offering our patients access to promising therapies when appropriate.
By working with us, you can expect:
We’re genuinely thrilled about the possibilities that Q-REstrain might offer, and we’re here to help you explore if it could be a part of your journey to better health. Let’s chat more about it if you’re curious!
Q-REstrain® therapy is designed to support patients navigating complex and difficult health conditions, including:
Solid Tumours: Designed to support a wide range of solid tumour types across different stages
Hematologic Malignancies: Includes blood-related cancers such as leukemia, lymphoma, and multiple myeloma
Please note: Q-REstrain® is not intended for cancers of the central nervous system (CNS).
Q-REstrain® is developed to address a broad spectrum of viral-related conditions, including:
Herpes Virus Family: HSV-1 / HSV-2, HHV-6, Varicella Zoster (shingles), Epstein–Barr Virus (EBV), Cytomegalovirus (CMV)
Human Papillomavirus (HPV): High- and low-risk strains including HPV 16/18 and 6/11
Hepatitis Viruses: Hepatitis B and Hepatitis C
Additional Viral Conditions: Coxsackie virus, HIV, HTLV-1
Q-REstrain® offers a targeted, personalized approach intended to support individuals dealing with Lyme disease and related co-infections, particularly in chronic or persistent cases.
The process of undergoing Q-REstrain is relatively straightforward. After a thorough medical evaluation, a personalized oligonucleotide sequence is created in a specialized laboratory based on your specific condition. Once prepared, the Q-REstrain is administered via an intravenous infusion. The treatment session typically lasts a few hours, and patients can usually resume their normal activities shortly after.
Patients may experience mild side effects following the infusion, such as fatigue or flu-like symptoms. These side effects are typically short-lived and resolve within a few days. In many cases, patients report feeling better within weeks of treatment as the oligonucleotides begin to disrupt the abnormal cells or pathogens in their bodies.
Because Q-REstrain is a relatively new treatment, ongoing monitoring is essential to ensure its effectiveness and adjust the treatment plan as necessary. Your healthcare provider will schedule follow-up appointments to assess your progress and determine if additional Q-REstrain sessions are required.
Q-REstrain is a personalized treatment that uses short DNA or RNA molecules called oligonucleotides to target and disrupt the genetic material of harmful cells or viruses. By interfering with the ability of these cells or viruses to grow and replicate, it may help patients with chronic conditions like cancer or viral infections, offering a less invasive alternative to traditional treatments like chemotherapy.
Q-REstrain may suit people with chronic conditions, particularly cancer or persistent viral infections. It is personalized based on the patient’s unique genetic makeup and can be an option for those who haven’t responded well to conventional treatments. However, not everyone is a candidate, and a healthcare provider will assess if Q-REstrain is right for you.
During Q-REstrain/SOT, a custom oligonucleotide sequence is administered via an intravenous infusion, usually lasting a few hours. Some patients may experience mild side effects like fatigue or flu-like symptoms. These typically resolve within a few days. You may start noticing improvements within a few weeks as the treatment disrupts harmful cells or pathogens in your body.
During Q-REstrain/SOT, a custom oligonucleotide sequence is administered via an intravenous infusion, usually lasting a few hours. Some patients may experience mild side effects like fatigue or flu-like symptoms. These typically resolve within a few days. You may start noticing improvements within a few weeks as the treatment disrupts harmful cells or pathogens in your body.
